Sign in

CIK 0001867096 · Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
871082097
Phone
844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 8-K Event Executive or director change · Regulation FD disclosure
  4. 8-K Event Other events
  5. 8-K Event Regulation FD disclosure
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 8-K Event Unregistered share sale · Other events
  9. 8-K Event Executive or director change · Regulation FD disclosure
  10. 8-K Event Unregistered share sale · Other events
  11. 8-K Event Shareholder vote results
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 8-K Event Executive or director change
  15. 10-K Report Annual Report
  16. 8-K Event Results of operations
  17. 8-K Event Regulation FD disclosure
  18. 8-K Event Results of operations
  19. 8-K Event Regulation FD disclosure
  20. 10-Q Report Quarterly Report

Page 1 of 4 · 79 filings